Moxifloxacin: all 217 studies that test it

Page 2 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• PRACTECAL-PKPD Sub StudyStatus unknownNCT04081077Phase 2/3
• Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy SubjectsCompletedNCT03958123Phase 1
• The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on MetabolismCompletedNCT03868657Not applicable
• A Two Chemoprophylaxis Approaches After Phacoemulsification SurgeryCompletedNCT03634852Phase 4
• Study to Evaluate the QT / QTc Interval Prolongation Potential of VericiguatCompletedNCT03504982Phase 1
• A Two-Part Phase 1 Study to Investigate the Safety and Tolerability of Supratherapeutic Dose of Zanubrutinib and Effect of Zanubrutinib on Cardiac Repolarization in Healthy SubjectsCompletedNCT03432884Phase 1
• Routine Therapy Plus Moxifloxacin in Advanced Breast CancerCompletedNCT03405168Phase 2
• A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and MoxifloxacinCompletedNCT03386279Phase 1
• Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of EndophthalmitisCompletedNCT03363295Phase 4
• A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy VolunteersCompletedNCT03258515Phase 1
• Optimizing the Antibiotic Treatment of Uncomplicated Acute AppendicitisActive, not recruitingNCT03236961Not applicable
• Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy VolunteersCompletedNCT02917200Phase 1
• Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.TerminatedNCT02770729Phase 3
• Evaluating Newly Approved Drugs for Multidrug-resistant TBCompletedNCT02754765Phase 3
• Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy ParticipantsCompletedNCT02735603Phase 1
• Study of the Effects of Intravenous Exenatide on Cardiac RepolarizationCompletedNCT02650479Phase 1
• Intracameral Moxifloxacin for Prevention of Postcataract EndophthalmitisCompletedNCT02595359Phase 2
• Intracameral Antibiotic Safety StudySuspendedNCT02590523Phase 3
• A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC IntervalCompletedNCT02537288Phase 1
• The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori InfectionTerminatedNCT02359331Not applicable
• Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting ConditionsCompletedNCT02322619Phase 1
• A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy ParticipantsCompletedNCT02271438Phase 1
• Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy VolunteersCompletedNCT02257398Phase 1
• A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female VolunteersCompletedNCT02236026Phase 1
• Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female SubjectsCompletedNCT02206204Phase 1
• Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female SubjectsCompletedNCT02136888Phase 1
• Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian VolunteersStatus unknownNCT02119091Phase 1
• A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc IntervalCompletedNCT02104648Phase 1
• Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCPCompletedNCT02098486Phase 2
• A Thorough Corrected QT Interval TrialCompletedNCT02073084Phase 1
• A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy SubjectsCompletedNCT02064348Phase 1
• Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female SubjectsCompletedNCT02050802Phase 1
• Study to Evaluate the Effect of GSK1265744 on Cardiac ConductionCompletedNCT02027454Phase 1
• Moxifloxacin in Situ Gel to Treat Periodontal Pocket.CompletedNCT02016157Phase 4
• Effect of Glucose on QTc Interval in Type 1 DiabetesCompletedNCT01984827Phase 1
• Genetics of QT Response to MoxifloxacinTerminatedNCT01936480Phase 4
• Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy SubjectsCompletedNCT01913002Phase 1
• The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy SubjectsCompletedNCT01876316Not applicable
• Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic DrugsCompletedNCT01871701Phase 1
• A Study to Investigate the Effect of PH-797804 on QTc IntervalCompletedNCT01862887Phase 1
• Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled TrialsCompletedNCT01799356Phase 4
• Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple TherapyCompletedNCT01792700Phase 4
• A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)CompletedNCT01775761Phase 1
• Bacteriology and Inflammation in BronchiectasisStatus unknownNCT01761214Not applicable
• A Study Study to Investigate the Effect on QT/QTc Interval of Moxifloxacin After a Single Dose in Healthy Male SubjectsCompletedNCT01756521Phase 1
• Evaluation of the Effect of ATX-101 on QT/QTc IntervalsCompletedNCT01706679Phase 1
• Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy VolunteersCompletedNCT01674218Phase 1
• Moxifloxacin_QT Study in Chinese Healthy VolunteerStatus unknownNCT01653990Not applicable
• A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy VolunteersCompletedNCT01643889Phase 1
• Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival FloraCompletedNCT01577342Not applicable
• A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy VolunteersCompletedNCT01516372Phase 1
• VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract SurgeryWithdrawnNCT01515826Phase 3
• 2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract SurgeryCompletedNCT01455233Phase 4
• To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult SubjectsCompletedNCT01449188Phase 1
• Albiglutide Thorough ECG Study in Healthy VolunteersCompletedNCT01406262Phase 1
• Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT01398072Phase 3
• Pharmacokinetics and Safety of MoxifloxacinTerminatedNCT01329250Phase 4
• Penetration of Moxifloxacin Into Liver Tissue of Patients Undergoing Liver Resection.CompletedNCT01302951Phase 4
• Treatment of Mycobacterium Xenopi Pulmonary InfectionCompletedNCT01298336Phase 3
• To Investigate the Effects of AZD1981 on the QT IntervalCompletedNCT01265641Phase 1
• The Optimization of Mycoplasm Pneumonia Antibiotic TherapyCompletedNCT01259141Not applicable
• Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial ConjunctivitisWithdrawnNCT01238783Phase 2
• Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability StudyCompletedNCT01158755Phase 2
• Antibiotic or Not in Non-purulent Exacerbations of COPD: a Trial of Security and EfficacyCompletedNCT01091493Phase 4
• Bioavailability, Food Effect and Safety, Tolerability of a New Oral Suspension in Comparison to the Marketed Moxifloxacin Tablet in Healthy AdultsCompletedNCT01073891Phase 1
• Safety and Efficacy of Moxidex OticTerminatedNCT01071902Phase 3
• Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB PatientsTerminatedNCT01055145Phase 3
• Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric PatientsCompletedNCT01049022Phase 1
• BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration PneumoniaCompletedNCT01045902Phase 3
• Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control ValidationCompletedNCT01014247Phase 1
• Study to Assess Cardiac Conduction of GSK1349572CompletedNCT00996021Phase 1
• A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal InfectionsCompletedNCT00952796Phase 4
• Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver AbscessCompletedNCT00895089Phase 4
• Effect of Moxifloxacin Versus Gatifloxacin on Corneal Epithelium Following Pterygium ExcisionStatus unknownNCT00892918Not applicable
• Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired PneumoniaTerminatedNCT00887276Phase 4
• Effect on Wound Healing of Vigamox Versus CravitCompletedNCT00840580Phase 4
• A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIsCompletedNCT00828971Phase 3
• Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat TuberculosisCompletedNCT00816426Phase 1
• Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole on Patients With Chronic PeriodontitisCompletedNCT00805558Phase 4
• Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)CompletedNCT00769171Phase 3
• Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract SurgeryCompletedNCT00758199Phase 4
• Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration FactorsStatus unknownNCT00752947Phase 4
• A Phase III Study of an Otic Formulation in Acute Otitis ExternaCompletedNCT00750633Phase 3
• TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.CompletedNCT00744809Phase 1
• Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or ConjunctivitisCompletedNCT00732446Phase 3
• A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired PneumoniaCompletedNCT00717561Phase 3
• Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active ComparatorsCompletedNCT00703313Phase 4
• Dosage Study for Vigamox Eye Drops Prior to Intravitreal InjectionsCompletedNCT00690313Phase 4
• Effects of Single Oral Dose Dapagliflozin QT StudyCompletedNCT00688493Phase 1
• Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.CompletedNCT00683865Phase 3
• Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With AveloxCompletedNCT00668304Phase 4
• Avelox for Treatment of Elderly Patients With Community Acquired PneumoniaCompletedNCT00665327Phase 4
• Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic BronchitisCompletedNCT00656747Phase 4
• Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy TubesCompletedNCT00579189Phase 3
• A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal InfiltratesTerminatedNCT00579020Phase 2
• A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube OtorrheaCompletedNCT00578773Phase 2
• A Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy TubesCompletedNCT00578474Phase 3
• Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic ShockCompletedNCT00534287Phase 3
• Study Evaluating the Effect of Lecozotan SR on the QTc IntervalCompletedNCT00499642Phase 1
• Phase 1 Thorough QT Study in Young Healthy VolunteersCompletedNCT00485667Phase 1

← Moxifloxacin overview